Sustaxyl 350

SUSTAXYL 350 BY KALPA PHARMACEUTICALS

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
- active substances: 350 mg/mL
testosterone propionate 42 mg
testosterone phenylpropionate 84 mg;
testosterone isocaproate 84 mg;
testosterone decanoate 140 mg;
- auxiliary substances: benzyl alcohol, peach or peanut oil.

DRUG DESCRIPTION

Transparent oily solution, light yellow to yellow in color, with a characteristic odor.

Sustaxyl 350 injectable anabolic steroid is composed of testosterone propionate, testosterone phenylpropionate, testosterone isocaproate and testosterone decanoate. This is a strong drug that has distinct androgenic and anabolic effect. Sustaxyl offers a steady and continuous release of testosterone from the injected site and is essential for building strength and large muscular mass. By containing the four testosterones, Sustaxyl 350 has a long term impact on blood levels and usually athletes and bodybuilders inject the drug twice a week.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Androgen; anabolic steroid; androgen ester; G03B A03.

PHARMACOLOGICAL PROPERTIES

Pharmacodynamics
Sustaxyl is composed of four testosterone esters (propionate, phenylpropionate, isocaproate and decanoate). Testosterone is the primary androgen hormone synthesized and released by the testicles. It is responsible for the growth and development of male sexual organs and secondary sexual characteristics (maturation of the prostate, seminal vesicles, penis and scrotum), male hair distribution (face, pubis, chest), laryngeal development, body muscles and fat distribution. Retains nitrogen, sodium, potassium and phosphorus, increases anabolism and reduces protein catabolism. Premature increase in plasma of testosterone concentration in the prepubertal period causes the epiphyses to close and the growth to stop. Stimulates the production of erythropoietin and erythrocytes. Through a feedback mechanism, it inhibits the secretion of pituitary luteinizing and folliculostimulating hormones and causes the suppression of spermatogenesis.

In women it inhibits pituitary gonadrophic function, ovarian function, mammary glands, endometrial atrophy. Due to its antagonistic action against estrogen, it is used in the treatment of uterine fibroids, endometriosis, breast cancer. Manifests beneficial action in the climacteric period.

Pharmacokinetics
The testosterone esters in this preparation have different absorption and elimination rates, which ensures a fast and prolonged effect (up to 4 weeks) after a single administration: testosterone propionate acts for the first 24 hours. Testosterone phenylpropionate and isocaproate begin to act over 24 hours after administration and last up to 2 weeks. Testosterone decanoate is the slowest after the onset of action, but with the longest duration. In the blood, about 98% of testosterone binds to a specific fraction of globulins, which binds testosterone and estradiol. Biotransformation occurs in the liver to various 17-ketosteroids, which after conjugation with glucuronic or sulfuric acid are excreted in the urine (approximately 90%). Approximately 6% of the absorbed preparation is excreted in the faeces in free form.

PROFILE

Half life: 7-8 days
Routes ofadministration: intramuscular injection
Dosage forms: (Men): 350-700 mg / 7 days; (Women): Not Recommended
Acne: yes
Water retention: yes (high)
High blood pressure: yes
Hepatotoxicity: no
Aromatase: yes (high, 100% of testosterone)
Progestogen activity: low
DHT (dehydrotestosterone) conversion: no
Decreased HPTA function (own testosterone production): yes (weak)
Anabolic activity: 100%
Androgenic activity: 100%
Detection time: 3 months after the last injection.

THERAPEUTICAL INDICATIONS

In men - androgenic deficiency after castration, eunucoidism, hypopituitarism, hormonal impotence, symptoms of male climax (decreased libido and physical and intellectual activity), some forms of infertility with impaired spermatogenesis, osteoporosis caused by insufficiency and; in women - hyperestrogenemia, uterine fibroids; endometriosis; breast cancer; osteoporosis.

Sustaxyl 350 has the property to maintain a positive level of quality muscles and it is not appropriate for preparation for competitions. The drug advances water retention, aromatizes quite easily and can be easily detected in the urine.

DOSES AND METHOD OF ADMINISTRATION

Deep intramuscular. The dose is determined individually depending on the patient's indications and reactivity. Usually, in adults, 1 mL of solution is administered intramuscularly over 14 days; to obtain the therapeutic effect - 1 mL intramuscularly over 28 days. The duration of treatment is determined individually.

In sterility in men (azospermia, oligospermia): 2 mL once in 2 weeks (when a painful erection occurs, treatment is stopped).

In breast cancer in women: 1-2 mL every 1-2 weeks, long-term treatment.

This drug is not administered intravenously!

For sport purposes Average Dosage: Men 250-850 mg per week, Women - 50-100 mg. The usual duration of a cycle would be from 8-20 weeks.

SIDE EFFECTS

Main side effects: mood changes (depression, anger, anxiety, insomnia), gynecomastia, hair loss, sexual related problems, retention of water, liver damage. Women can experience virilization effects as voice deepening, hair loss or clitoris enlargement.

- Priapism and other symptoms of sexual hyperstimulation (frequent erection);
- in adolescents of prepubertal age - accelerating sexual development; increase in the frequency of erections, increase in the sexual organ in size, premature closure of the epiphyses;
- impaired spermatogenesis and disorders of sperm maturation, oligospermia and reduced ejaculate volume;
- prostate abnormalities;
- in women - bleeding from the genitals, increased libido; symptoms of virilization are possible with prolonged administration;
- hirsutism, gynecomastia;
- seborrhea, acne, oily skin, hair loss;
- sodium and water retention, edema;
- symptoms of hypercalcaemia;
- thrombophlebitis;
- nausea, cholestatic jaundice, increased levels of liver transaminases (normalizes when treatment is stopped);
- headache, depression, aggression, anxiety, sleep disorders, paresthesias.

Pain, pruritus and hyperemia at the injection site are possible.

CONTRAINDICATIONS

Individual hypersensitivity to the drug, prostate or breast cancer; prostate hyperplasia with symptoms of urinary disorders; nephrosis or nephrotic phase of nephritis, edema; hypercalcemia; liver function disorders; diabetes; heart or coronary insufficiency, a history of myocardial infarction, atherosclerosis in elderly men; pregnancy, lactation.

OVERDOSE

In acute overdose the toxicity of testosterone is quite low. In chronic overdose it is possible to develop priapism. In this case it is necessary to stop the administration of this drug, and after the disappearance of symptoms - to resume treatment in lower doses.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

In case of androgen-dependent side effects it is necessary to stop the administration of this drug. After the disappearance of the side effects, resume treatment in lower doses.

Patients with latent or overt heart failure, renal impairment, hypertension, epilepsy or migraine (or a history of these conditions) will be under constant supervision, as androgens may in some cases cause sodium and water retention. Liver function will be monitored during long-term treatment. In patients with breast cancer, hypernephroma, lung cancer with bone metastases, the level of calcium in the blood and urine will be controlled. In adolescents in the prepubertal period, androgens should be administered with caution to avoid stopping growth and premature puberty.

INTERACTIONS WITH OTHER DRUGS

Increases the effectiveness of anticoagulants and antidiabetics (dose adjustment is required), inhibits the elimination of cyclosporine. Inducers of liver enzymes (barbiturates, rifampicin, carbamazepine, phenylbutazone, phenytoin) reduce the effect of testosterone.

If you still want to buy Sustaxyl 350, then it can be stacked with other steroids such as Dianabol, Oxymetholone, Trenbolone, as well as with anti-estrogens such as Anastrozole, Proviron, Tamoxifen.

PRESENTATION, PACKAGING

Injectable oily solution 350 mg / 1 mL in 10 mL vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

May 2020

NAME AND ADDRESS OF THE MANUFACTURER

Kalpa Pharmaceuticals LTD.
India
www.kalpapharmaceuticals.com

EXTERNAL LINKS

Sustaxyl 350 Lab Test Results >> PDF

Testosterone >> Wikipedia

Sustaxyl 350 Reviews >> GrowXXL

Kalpa Pharmaceuticals Reviews >> GrowXXL

Testosterone for Sale >> Top Suppliers

Sustanon Online >> Top Suppliers